The $15 billion acquisition of a California maker of vascular devices is Boston Scientific's biggest since 2006.
Penumbra deal is major milestone for Boston Scientific CEO Mahoney
The $15 billion acquisition of a California maker of vascular devices is Boston Scientific's biggest since 2006.
